• Glycogen Colorimetric Assay Kit II: Advancing Tissue Glycoge

  2026-05-07

  Discover how the Glycogen Colorimetric Assay Kit II enables precise, interference-resistant glycogen quantification in research on circadian metabolism and exercise adaptation. This article explores advanced assay mechanisms, protocol refinements, and new scientific insights.

• SHC-1 Inhibition Elevates CFTR Membrane Abundance in Epithel

  2026-05-06

  This study establishes SHC-1 as a conserved mediator of CFTR internalization through the MAPK pathway across several epithelial cell models. By pharmacologically inhibiting SHC-1, the authors demonstrate cell-type-specific increases in CFTR plasma membrane abundance, informing the design of translational cystic fibrosis and secretory disease research assays.

• Sulfo-NHS-Biotin: Precision Surface Labeling for Translation

  2026-05-06

  Explore the mechanistic depth, strategic value, and transformative impact of Sulfo-NHS-Biotin in modern translational research. This article bridges foundational biochemistry, cutting-edge single-cell proteogenomics, and practical guidance for next-generation cell therapy and molecular profiling. By integrating evidence from SEC-seq studies and benchmarking against contemporary biotinylation reagents, we offer translational researchers a roadmap to reproducible, high-fidelity cell surface protein labeling—unlocking new avenues in cell sorting, functional genomics, and therapeutic development. Internal links expand scenario-based troubleshooting and protocol optimization, while forward-looking analysis situates Sulfo-NHS-Biotin at the vanguard of single-cell resolution biological discovery.

• Nintedanib (BIBF 1120): Optimized Antiangiogenic Workflows

  2026-05-05

  Nintedanib (BIBF 1120) is a triple angiokinase inhibitor that empowers researchers to dissect angiogenesis inhibition pathways in cancer and fibrosis models. This article delivers actionable protocol enhancements, troubleshooting guides, and advanced use-case insights—directly leveraging the latest evidence and APExBIO’s trusted supply chain.

• Machine Learning Uncovers Ferroptosis Biomarkers in Vascular

  2026-05-05

  This paper applies interpretable machine learning to identify and validate ferroptosis-related genes as predictive biomarkers of vascular calcification (VC), integrating SHAP and LIME for model explanation. The findings illuminate the molecular link between ferroptosis and VC, offering new targets for diagnostic and mechanistic research.

• High-Throughput BBB Surrogate Model: Integrating Lysosomal T

  2026-05-04

  This study presents a high-throughput in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells, incorporating lysosomal trapping correction to improve predictive accuracy for CNS drug permeability. The model enables early-stage triage of drug candidates by emulating key BBB features and correlating in vitro permeability with in vivo brain distribution.

• Micro- and Nanoplastics Drive Pulmonary Fibrosis via FXR-YAP

  2026-05-04

  This study provides direct comparative evidence that inhaled microplastics and nanoplastics, particularly polystyrene nanoplastics, induce pulmonary fibrosis through FXR-YAP1 axis dysregulation. The findings highlight the size- and polymer-dependent pulmonary toxicity of emerging plastic pollutants and underscore mechanistic targets for environmental toxicology research.

• AT13387: Optimizing Hsp90 Inhibitor Workflows in Cancer Biol

  2026-05-03

  AT13387’s distinct scaffold and potent Hsp90 inhibition empower researchers to induce apoptosis and cell cycle arrest with high specificity in cancer models. This guide details stepwise protocols, troubleshooting strategies, and practical assay choices that leverage AT13387’s unique advantages for advanced cancer biology research.

• Nelfinavir Mesylate: Bridging HIV Inhibition and Ferroptosis

  2026-05-02

  This thought-leadership article explores the expanding utility of Nelfinavir Mesylate as both a benchmark HIV-1 protease inhibitor and a strategic tool for manipulating ferroptosis via the ubiquitin-proteasome system. Translational researchers will find actionable guidance integrating mechanistic insights, protocol parameters, and workflow design for cutting-edge virology, oncology, and protein homeostasis studies. Key evidence from recent literature is synthesized and contextualized, escalating the conversation beyond traditional product pages and highlighting new frontiers powered by APExBIO’s Nelfinavir Mesylate.

• PtrbZIP12 Phosphorylation Directs Drought Response in Poplar

  2026-05-02

  This study elucidates how phosphorylation of the bZIP transcription factor PtrbZIP12 enhances drought resistance in Populus trichocarpa through direct regulation of stress-response genes. The findings clarify the role of post-translational modification in plant adaptation and provide methodological advances for protein phosphorylation analysis.

• Cdc42 Inhibition Mitigates Renal Fibrosis via β-Catenin Modu

  2026-05-01

  A recent study identifies Cdc42 as a central regulator of kidney fibrosis and demonstrates that direct inhibition of Cdc42 suppresses pro-fibrotic GSK-3β/β-catenin signaling in renal models. This work highlights a mechanistically validated strategy for attenuating fibrosis, supporting the use of selective Cdc42 inhibitors for advanced kidney disease research.

• Nonivamide (Capsaicin Analog): Applied Protocols in Cancer a

  2026-04-30

  Nonivamide, a selective TRPV1 agonist, is redefining experimental cancer and inflammation models with its robust anti-proliferative and neuroimmune-modulating properties. This article delivers actionable workflows, protocol optimization, and troubleshooting insights, all anchored in the latest reference findings and comparative literature.

• UHRF1, DNA Methylation, and Super-Enhancer Dynamics in Osteo

  2026-04-30

  This study uncovers how UHRF1-mediated DNA 5-mC modification drives redistribution of super-enhancers and impedes osteogenic differentiation in senile osteoporosis via TGM2-regulated autophagic flux. These findings reveal an intricate epigenetic mechanism linking DNA methylation, enhancer landscape alterations, and impaired mesenchymal stem cell function, highlighting new directions for targeted osteoporosis research.

• Machine Learning Discovers Novel Senolytics for Targeting Ce

  2026-04-29

  This article reviews a recent study that leveraged machine learning to identify novel senolytic compounds capable of selectively eliminating senescent cells. The findings highlight both the promise and the challenges of AI-based drug discovery for aging and cancer research.

• ATRX Loss Sensitizes High-Grade Glioma to RTK/PDGFR Inhibito

  2026-04-29

  Pladevall-Morera et al. identify that high-grade glioma cells lacking ATRX are especially susceptible to multi-targeted RTK and PDGFR inhibitors. This work highlights ATRX status as a potential biomarker for therapy stratification and suggests new avenues for targeted combination treatments in aggressive gliomas.

451 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page